ICHR vs LRCX: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ICHR and LRCX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ICHR and LRCX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Ichor Holdings designs, engineers, and manufactures critical fluid delivery subsystems and components used in the tools that make semiconductors. Its core products are gas delivery subsystems (which deliver, monitor, and control the specialty gases used in etch and deposition) and chemical delivery subsystems (which blend and dispense the reactive liquids used in electroplating and cleaning). Ichor acts as a turnkey outsourcing partner to major original equipment manufacturers, letting them hand off non-critical elements of tool design, production, and support. The company is headquartered in Fremont, California, and was incorporated in 1999.

Full ICHR guide

Lam Research is one of the largest semiconductor equipment makers in the world, specializing in wafer-fabrication tools used to build integrated circuits. It is a leader in two critical process steps: etch (precisely removing material to carve nanoscale features) and deposition (laying down ultra-thin films of material), along with related cleaning and surface-preparation systems. These steps are repeated hundreds of times to build modern 3D chip structures, and Lam's tools are essential to manufacturing advanced logic and especially memory chips (DRAM and NAND flash). Lam sells its systems to the world's leading chipmakers and foundries, then earns a large, recurring stream of revenue from spare parts, upgrades, and services for its big installed base of tools, which smooths the cyclical equipment-sales business. Demand is driven by capital spending from semiconductor manufacturers, which rises and falls with chip-industry cycles but trends structurally higher as AI, data centers, and advanced devices require more and more sophisticated chips. Headquartered in Fremont, California, Lam is a key enabler of leading-edge and memory chip production.

Full LRCX guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ICHR drivers: Semiconductor capital equipment recovery; Margin expansion through proprietary content.
• LRCX drivers: AI-driven chip-capex supercycle; Leadership in etch and deposition.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Customer concentration is severe: Lam Research and Applied Materials together account for the large majority of revenue (roughly 87 percent by one industry estimate), so a pullback in orders from either would hit results hard. For LRCX, semiconductor equipment is highly cyclical, and Lam's new-tool sales swing sharply with chipmaker capital-spending cycles, especially in memory, which is among the most volatile end markets.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ICHR if you believe its drivers more; LRCX if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ICHR and LRCX guides.

ICHR. As of May 2026 Ichor carried a market cap near $3.4 billion on roughly $960 million in trailing revenue, valuing it at close to 3.5 times sales despite thin gross margins. The company reported a non-GAAP profit in Q1 2026 (about $0.15 per share) but a GAAP loss, and 2025 as a whole was a GAAP net loss of about $52.8 million. Its valuation reflects expectations for a semiconductor upcycle and margin recovery rather than current earnings.

LRCX. Lam trades at a multiple reflecting both strong secular demand for chip equipment and the cyclicality of the memory-heavy equipment market. The valuation embeds expectations of a structural rise in semiconductor capital spending driven by AI, balanced against export-control risk and the swing factor of memory capex. The large, higher-margin installed-base service revenue supports a premium over a purely cyclical equipment maker. Lam also returns substantial cash through buybacks and a growing dividend.

Headline figures (approximate, MAY 2026): ICHR shows revenue (2025) ~$948M, revenue (ttm) ~$960M, q1 2026 revenue ~$256M, q1 2026 gross margin ~12.6%; LRCX shows revenue (ttm) ~$16 billion, operating margin ~30%, net income (ttm) ~$4-5 billion, p/e (ttm) ~25x.

ICHR and LRCX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ICHR and LRCX exposure against your real portfolio. It is not an investment adviser.